共 137 条
[1]
Brink I(2005)Imaging of pheochromocytoma and paraganglioma Fam Cancer 4 61-68
[2]
Hoegerle S(2009)Comparison of 18F-fluoro-L-DOPA, 18F-fluorodeoxyglucose, and 18F-fluorodopamine PET and 123I-MIBG scintigraphy in the localization of pheochromocytoma and paraganglioma J Clin Endocrinol Metab 94 4757-4767
[3]
Klisch J(1999)Nuclear medicine imaging of pheochromocytoma and neuroblastoma Q J Nucl Med 43 217-223
[4]
Bley TA(1994)Metaiodobenzylguanidine and somatostatin in oncology: role in the management of neural crest tumours Eur J Nucl Med 21 561-581
[5]
Timmers HJ(2013)The evolution in the use of MIBG scintigraphy in pheochromocytomas and paragangliomas Hormones (Athens) 12 58-68
[6]
Chen CC(2002)Pheochromocytomas: detection with 18F DOPA whole body PET—initial results Radiology 222 507-512
[7]
Carrasquillo JA(1998)Current concepts on the diagnostic use of MIBG in children J Nucl Med 39 679-688
[8]
Chen CC(1997)Specificity of radioiodinated MIBG for neural crest tumors in childhood J Nucl Med 38 1352-1357
[9]
Whatley M(2008)111In-octreotide is superior to 123I-metaiodobenzylguanidine for scintigraphic detection of head and neck paragangliomas J Nucl Med 49 1232-1237
[10]
Ling A(1996)Neuroblastoma: positron emission tomography with 2‑[fluorine-18]-fluoro-2-deoxy-D-glucose compared with metaiodobenzylguanidine scintigraphy Radiology 199 743-750